Last10K.com

Zealand Pharma As (ZEAL) SEC Filing 6-K Foreign Issuer report for the period ending Friday, October 26, 2018

Zealand Pharma As

HISTORY TOOLS
CIK: 1674988 Ticker: ZEAL

View differences made from one to another to evaluate Zealand Pharma As's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Zealand Pharma As.

Continue

Assess how Zealand Pharma As's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Zealand Pharma As's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Zealand Pharma As provided additional information to their SEC Filing as exhibits

Exhibit 3.1: Articles Of Incorporation
Ticker: ZEAL
CIK: 1674988
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001104659-18-064072
Submitted to the SEC: Fri Oct 26 2018 9:22:40 AM EST
Accepted by the SEC: Fri Oct 26 2018
Period: Friday, October 26, 2018
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/zeal/0001104659-18-064072.htm